Connect with us

Medical

CTTI and FDA Public Workshop on Enhancing the Incorporation of Patient Perspectives in Clinical Trials – 03/18/2019

Claudia Baldwin

Published

on

On March 18, 2019, the Clinical Trials Transformation Initiative (CTTI) and FDA held a public workshop, “Enhancing the Incorporation of Patient Perspectives in Clinical Trials.” This workshop met an FDA commitment that is part of the sixth authorization of PDUFA VI.

Original Post: fda.gov

Medical

FDA Approves Neoadjuvant Nivolumab and Platinum-doublet Chemotherapy for Early-stage Non-small Cell Lung Cancer

Claudia Baldwin

Published

on

By

FDA approves neoadjuvant nivolumab and platinum-doublet chemotherapy for early-stage non-small cell lung cancer

Original Article: fda.gov

Continue Reading

Medical

Data Standards Program Strategic Plan and Board

Claudia Baldwin

Published

on

By

The Data Standards Strategy reinforces CDER’s ongoing commitment to the development, implementation, and maintenance of a comprehensive data standards program that will facilitate the efficient and effective review of regulatory submissions. This helps bring safe and effective products to market.

Original Source: fda.gov

Continue Reading

Medical

First Generic Drug Approvals

Claudia Baldwin

Published

on

By

Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for patients. “First generics” are just what they sound like—the first approval by FDA which permits a manufacturer to market a generic drug product in the United States.

Original Article: fda.gov

Continue Reading

Trending

WVPU.com